CLC number:
On-line Access: 2025-01-14
Received: 2023-10-19
Revision Accepted: 2024-02-20
Crosschecked: 2024-06-11
Cited: 0
Clicked: 951
Miaomiao ZHAO, Ying LI, Haoyang ZHAO, Chaonan JIANG, Manli HUANG. Repetitive transcranial magnetic stimulation combined with imaginal exposure therapy for adolescents with acute stress disorder: case report[J]. Journal of Zhejiang University Science B, 2025, 26(1): 52-57.
@article{title="Repetitive transcranial magnetic stimulation combined with imaginal exposure therapy for adolescents with acute stress disorder: case report",
author="Miaomiao ZHAO, Ying LI, Haoyang ZHAO, Chaonan JIANG, Manli HUANG",
journal="Journal of Zhejiang University Science B",
volume="26",
number="1",
pages="52-57",
year="2025",
publisher="Zhejiang University Press & Springer",
doi="10.1631/jzus.B2300765"
}
%0 Journal Article
%T Repetitive transcranial magnetic stimulation combined with imaginal exposure therapy for adolescents with acute stress disorder: case report
%A Miaomiao ZHAO
%A Ying LI
%A Haoyang ZHAO
%A Chaonan JIANG
%A Manli HUANG
%J Journal of Zhejiang University SCIENCE B
%V 26
%N 1
%P 52-57
%@ 1673-1581
%D 2025
%I Zhejiang University Press & Springer
%DOI 10.1631/jzus.B2300765
TY - JOUR
T1 - Repetitive transcranial magnetic stimulation combined with imaginal exposure therapy for adolescents with acute stress disorder: case report
A1 - Miaomiao ZHAO
A1 - Ying LI
A1 - Haoyang ZHAO
A1 - Chaonan JIANG
A1 - Manli HUANG
J0 - Journal of Zhejiang University Science B
VL - 26
IS - 1
SP - 52
EP - 57
%@ 1673-1581
Y1 - 2025
PB - Zhejiang University Press & Springer
ER -
DOI - 10.1631/jzus.B2300765
Abstract: acute stress disorder (ASD) is a transient psychiatric disorder that may arise subsequent to abrupt, extreme trauma exposure, and serves as a reliable indicator for the subsequent development of posttraumatic stress disorder (PTSD) (Bryant, 2011; Battle, 2013). It exhibits rapid progression in the aftermath of trauma and persists for a duration of days or weeks (not exceeding one month), manifesting symptoms of dissociation, re-experiencing, avoidance, and hyperarousal (Bielas et al., 2018). In the absence of efficacious and prompt intervention, ASD is linked to substantial morbidity and functional impairment (McLean et al., 2022). However, there is a deficiency in terms of providing sensitive diagnosis and effective treatment for adolescents diagnosed with ASD, with the majority of current approaches being derived from PTSD treatment. The prevailing strategies for addressing PTSD in children and young individuals primarily involve psychological intervention and pharmaceuticals, including selective serotonin reuptake inhibitors (SSRIs) (Smith et al., 2013). Nevertheless, the efficacy of SSRIs in adolescents with ASD remains suboptimal (Robb et al., 2010; Locher et al., 2017; Boaden et al., 2020).
[1]BattleDE, 2013. Diagnostic and statistical manual of mental disorders (DSM). Codas, 25(2):191-192.
[2]BerlimMT, van den EyndeF, 2014. Repetitive transcranial magnetic stimulation over the dorsolateral prefrontal cortex for treating posttraumatic stress disorder: an exploratory meta-analysis of randomized, double-blind and sham-controlled trials. Can J Psychiatry, 59(9):487-496.
[3]BielasH, Meister-LangrafRE, SchmidJP, et al., 2018. Acute stress disorder and C-reactive protein in patients with acute myocardial infarction. Eur J Prev Cardiol, 25(3):298-305.
[4]BoadenK, TomlinsonA, CorteseS, et al., 2020. Antidepressants in children and adolescents: meta-review of efficacy, tolerability and suicidality in acute treatment. Front Psychiatry, 11:717.
[5]BryantRA, 2011. Acute stress disorder as a predictor of posttraumatic stress disorder: a systematic review. J Clin Psychiatry, 72(2):233-239.
[6]BryantRA, 2018. The current evidence for acute stress disorder. Curr Psychiatry Rep, 20(12):111.
[7]GaynesBN, LloydSW, LuxL, et al., 2014. Repetitive transcranial magnetic stimulation for treatment-resistant depression: a systematic review and meta-analysis. J Clin Psychiatry, 75(5):477-489.
[8]GeorgeMS, NahasZ, MolloyM, et al., 2000. A controlled trial of daily left prefrontal cortex TMS for treating depression. Biol Psychiatry, 48(10):962-970.
[9]GeorgeMS, LisanbySH, AveryD, et al., 2010. Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trial. Arch Gen Psychiatry, 67(5):507-516.
[10]HerringaRJ, 2017. Trauma, PTSD, and the developing brain. Curr Psychiatry Rep, 19(10):69.
[11]HoffmanRE, CavusI, 2002. Slow transcranial magnetic stimulation, long-term depotentiation, and brain hyperexcitability disorders. Am J Psychiatry, 159(7):1093-1102.
[12]HuangYZ, EdwardsMJ, BhatiaKP, et al., 2004. One-Hz repetitive transcranial magnetic stimulation of the premotor cortex alters reciprocal inhibition in DYT1 dystonia. Mov Disord, 19(1):54-59.
[13]IglesiasAH, 2020. Transcranial magnetic stimulation as treatment in multiple neurologic conditions. Curr Neurol Neurosci Rep, 20:1.
[14]IsserlesM, TendlerA, RothY, et al., 2021. Deep transcranial magnetic stimulation combined with brief exposure for posttraumatic stress disorder: a prospective multisite randomized trial. Biol Psychiatry, 90(10):721-728.
[15]JiangC, LiZS, WangJJ, et al., 2023. Effectiveness of repetitive transcranial magnetic stimulation combined with a brief exposure procedure for post-stroke posttraumatic stress disorder. J Affect Disord, 326:89-95.
[16]KaczkurkinAN, FoaEB, 2015. Cognitive-behavioral therapy for anxiety disorders: an update on the empirical evidence. Dialogues Clin Neurosci, 17(3):337-346.
[17]KlomjaiW, KatzR, Lackmy-ValléeA, 2015. Basic principles of transcranial magnetic stimulation (TMS) and repetitive TMS (rTMS). Ann Phys Rehabil Med, 58(4):208-213.
[18]KozelFA, 2018. Clinical repetitive transcranial magnetic stimulation for posttraumatic stress disorder, generalized anxiety disorder, and bipolar disorder. Psychiatr Clin North Am, 41(3):433-446.
[19]KozelFA, van TreesK, LarsonV, et al., 2019. One hertz versus ten hertz repetitive TMS treatment of PTSD: a randomized clinical trial. Psychiatry Res, 273:153-162.
[20]LocherC, KoechlinH, ZionSR, et al., 2017. Efficacy and safety of selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, and placebo for common psychiatric disorders among children and adolescents: a systematic review and meta-analysis. JAMA Psychiatry, 74(10):1011-1020.
[21]MarchJS, 2003. Acute stress disorder in youth: a multivariate prediction model. Biol Psychiatry, 53(9):809-816.
[22]McLeanCP, LevyHC, MillerML, et al., 2022. Exposure therapy for PTSD: a meta-analysis. Clin Psychol Rev, 91:102115.
[23]MiladMR, RauchSL, PitmanRK, et al., 2006. Fear extinction in rats: implications for human brain imaging and anxiety disorders. Biol Psychol, 73(1):61-71.
[24]O'NealMA, BasletG, 2018. Treatment for patients with a functional neurological disorder (conversion disorder): an integrated approach. Am J Psychiatry, 175(4):307-314.
[25]OsuchEA, BensonBE, LuckenbaughDA, et al., 2009. Repetitive TMS combined with exposure therapy for PTSD: a preliminary study. J Anxiety Disord, 23(1):54-59.
[26]PanMR, HuangF, ZhaoMJ, et al., 2019. A comparison of efficacy between cognitive behavioral therapy (CBT) and CBT combined with medication in adults with attention-deficit/hyperactivity disorder (ADHD). Psychiatry Res, 279:23-33.
[27]PhilipNS, BarredoJ, AikenE, et al., 2019. Theta-burst transcranial magnetic stimulation for posttraumatic stress disorder. Am J Psychiatry, 176(11):939-948.
[28]RobbAS, CuevaJE, SpornJ, et al., 2010. Sertraline treatment of children and adolescents with posttraumatic stress disorder: a double-blind, placebo-controlled trial. J Child Adolesc Psychopharmacol, 20(6):463-471.
[29]SimmonsA, MatthewsSC, SteinMB, et al., 2004. Anticipation of emotionally aversive visual stimuli activates right insula. NeuroReport, 15(14):2261-2265.
[30]SmithP, PerrinS, DalgleishT, et al., 2013. Treatment of posttraumatic stress disorder in children and adolescents. Curr Opin Psychiatry, 26(1):66-72.
[31]WhiteLK, MakhoulW, TeferiM, et al., 2023. The role of dlPFC laterality in the expression and regulation of anxiety. Neuropharmacology, 224:109355.
Open peer comments: Debate/Discuss/Question/Opinion
<1>